Latest Insider Transactions at Revolution Medicines, Inc. (RVMD)
This section provides a real-time view of insider transactions for Revolution Medicines, Inc. (RVMD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revolution Medicines, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revolution Medicines, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2026
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.47%
|
$980,000
$98.0 P/Share
|
|
Jan 07
2026
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.81%
|
$420,000
$42.45 P/Share
|
|
Jan 07
2026
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
75,000
-12.72%
|
$7,575,000
$101.57 P/Share
|
|
Jan 07
2026
|
Margaret A Horn Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+15.46%
|
$2,700,000
$36.13 P/Share
|
|
Dec 16
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,104
-2.79%
|
$239,008
$77.09 P/Share
|
|
Dec 16
2025
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,847
-3.32%
|
$368,372
$76.82 P/Share
|
|
Dec 16
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
5,447
-1.92%
|
$413,972
$76.82 P/Share
|
|
Dec 16
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
15,394
-6.21%
|
$1,169,944
$76.82 P/Share
|
|
Dec 16
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,688
-5.32%
|
$204,288
$76.82 P/Share
|
|
Nov 25
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
6,000
-4.26%
|
$450,000
$75.0 P/Share
|
|
Nov 25
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
60,000
-19.49%
|
$4,500,000
$75.08 P/Share
|
|
Nov 25
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+16.31%
|
$240,000
$4.09 P/Share
|
|
Nov 25
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,418
-4.65%
|
$400,932
$74.0 P/Share
|
|
Nov 25
2025
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,418
+4.45%
|
$92,106
$17.0 P/Share
|
|
Nov 18
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
13,388
-20.98%
|
$937,160
$70.14 P/Share
|
|
Nov 18
2025
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,388
+17.34%
|
$562,296
$42.45 P/Share
|
|
Nov 18
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
20,000
-7.47%
|
$1,400,000
$70.38 P/Share
|
|
Nov 18
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.95%
|
$80,000
$4.09 P/Share
|
|
Nov 12
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
20,000
-7.47%
|
$1,300,000
$65.07 P/Share
|
|
Nov 12
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.95%
|
$80,000
$4.09 P/Share
|
|
Nov 12
2025
|
Mark A Goldsmith |
BUY
Bona fide gift
|
Indirect |
100,000
+44.68%
|
-
|
|
Nov 12
2025
|
Mark A Goldsmith |
SELL
Bona fide gift
|
Direct |
100,000
-15.58%
|
-
|
|
Nov 11
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-8.26%
|
$640,000
$64.0 P/Share
|
|
Nov 11
2025
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.63%
|
$170,000
$17.0 P/Share
|
|
Nov 07
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
30,000
-7.94%
|
$1,800,000
$60.31 P/Share
|
|
Nov 07
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+3.76%
|
$60,000
$2.61 P/Share
|
|
Oct 17
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-2.16%
|
$550,000
$55.0 P/Share
|
|
Oct 17
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.12%
|
$10,000
$1.12 P/Share
|
|
Oct 17
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
12,000
-19.22%
|
$660,000
$55.0 P/Share
|
|
Oct 17
2025
|
Jeff Cislini General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+16.12%
|
$432,000
$36.57 P/Share
|
|
Oct 16
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-2.16%
|
$500,000
$50.47 P/Share
|
|
Oct 16
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.12%
|
$10,000
$1.12 P/Share
|
|
Oct 13
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
25,000
-8.09%
|
$1,200,000
$48.54 P/Share
|
|
Oct 13
2025
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.48%
|
$100,000
$4.73 P/Share
|
|
Sep 24
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,799
-3.44%
|
$79,156
$44.26 P/Share
|
|
Sep 16
2025
|
Lin Wei Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,160
-2.39%
|
$97,200
$45.82 P/Share
|
|
Sep 16
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,320
-2.05%
|
$104,400
$45.82 P/Share
|
|
Sep 16
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,869
-3.46%
|
$84,105
$45.82 P/Share
|
|
Sep 16
2025
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,775
-3.17%
|
$214,875
$45.82 P/Share
|
|
Sep 16
2025
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
13,411
-2.88%
|
$603,495
$45.82 P/Share
|
|
Sep 16
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
5,367
-1.85%
|
$241,515
$45.82 P/Share
|
|
Sep 15
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
25,000
-3.99%
|
$1,150,000
$46.42 P/Share
|
|
Sep 15
2025
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.37%
|
$100,000
$4.73 P/Share
|
|
Sep 11
2025
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
100,000
-13.76%
|
$4,400,000
$44.03 P/Share
|
|
Sep 11
2025
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+20.43%
|
$400,000
$4.73 P/Share
|
|
Sep 03
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,238
-4.42%
|
$209,520
$40.17 P/Share
|
|
Sep 03
2025
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,238
+2.18%
|
$52,380
$10.87 P/Share
|
|
Sep 02
2025
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,762
-4.03%
|
$190,480
$40.02 P/Share
|
|
Sep 02
2025
|
Jack Anders Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,762
+1.99%
|
$14,286
$3.71 P/Share
|
|
Jun 30
2025
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
37,000
+7.36%
|
$0
$0.54 P/Share
|